Dry eye/OSD

Nanoparticle ophthalmic solution improves signs/symptoms of dry eye

A recent study to evaluate the safety and efficacy of a nanoparticle ophthalmic suspension of loteprednol etabonate (Eysuvis, Kala Pharmaceuticals) for the treatment of dry eye disease (DED) found that the suspension rapidly improved both signs and symptoms of the condition and appeared to be safe and well-tolerated, according to...